All news
-
Presse
- Galerie d'images documentaires
- Vidéogrammes
- Safer chemicals podcast
-
Sujets scientifiques brûlants
- La prévention du cancer
- Produits chimiques sensibilisants cutanés
- Substances per- et polyfluoroalkylées (PFAS)
- Microplastiques
- Granules et paillis sur les terrains
- Encres de tatouage et maquillage permanent
- Glyphosate
- Perturbateurs endocriniens
- Bisphénols
- Stratégie pour la durabilité dans le domaine des produits chimiques
- Les essais sur les animaux dans le cadre de REACH
- Phtalates
- Biocides
- Plomb
- Research to enhance protection of our health and environment
- Corporate and visual Identity
- ECHA Articles
All news
Member States start evaluating 21 substances in 2018
ECHA/NR/18/17
ECHA has adopted the updated Community rolling action plan (CoRAP) with 108 substances to be evaluated in 2018-2020. Registrants of the listed substances are encouraged to coordinate their actions and contact the evaluating Member States.
Helsinki, 20 March 2018 – In the coming three years, 20 Member States plan to evaluate 108 substances. The authorities have 12 months to evaluate the 21 substances specified for 2018. The aim is to clarify whether these substances pose a risk to people or the environment. If necessary, the registrants will be asked to provide further information on the substance so that authorities can assess the suspected concern.
ECHA encourages registrants of the listed substances to coordinate their actions and to contact the evaluating Member State. Registrants are also urged to update their dossiers, especially for uses and exposure scenarios. They will have an opportunity to comment before any decision to request further information is taken. Such draft decisions will be reviewed by the other Member States and ECHA before the final decision is issued.
The substances are selected for evaluation to clarify the concerns related to their exposure and suspected serious hazard properties: persistent, bioaccumulative and toxic (PBT), carcinogenic, mutagenic and reprotoxic (CMR), or endocrine disruptors in combination with wide dispersive consumer use. Also other concerns on the substances may be identified during evaluation.
- 2018-2020 CoRAP list [EN] [PDF]
- Opinion of the Member State Committee on ECHA’s annual CoRAP update for 2018-2020 [EN] [PDF]
- Annex to the Opinion on ECHA’s annual CoRAP update for 2018-2020 [EN] [PDF]
- CoRAP web pages
- Registrant’s guide - How to act in substance evaluation [EN] [PDF]
- Recommendations for interaction between registrants and the evaluating Member States [EN] [PDF]